Clinical dilemmas in viral liver disease. (2020)

• Record Type: Book
• Further Information: Note: Edited by Graham R. Foster, K. Rajender Reddy.
• Editors: Foster, Graham R; Reddy, K. Rajender
• Contents: List of Contributors vii Preface xi Part I: Investigating the Liver 1 Noninvasive markers of fibrosis: how reliable are they? 3; Laurent Castera 2 Liver biopsy in chronic viral hepatitis: is there still life left in it? 9; Jaspreet Suri and Michael P. Curry 3 Screening for hepatocellular carcinoma in viral liver disease: any new biomarkers on the horizon? 15; Saroja Bangaru, Jorge A. Marrero, and Amit G. Singal 4 Realistic estimates of hepatitis C virus and hepatitis B virus disease burden 19; Homie Razavi Part II: Today’s Therapies Section 1: HCV 5 Acute hepatitis C: treat immediately or give a chance to spontaneously clear? 29; David E. Kaplan 6 Is ribavirin alive or dead in the current era of HCV therapy? 35; Vijay Prabhakar and Paul Y. Kwo 7 Hepatitis C virus genotype and viral testing, and on‐treatment monitoring: necessary or overkill? 41; Sirina Ekpanyapong and K. Rajender Reddy 8 Treatment of hepatitis C virus in renal disease: can we use all the drugs without additional monitoring? 48; Stanislas Pol 9 Does directly acting antiviral therapy improve quality of life? 54; Daniel M. Forton 10 Morbid obesity and hepatitis C: treat as normal or are there additional issues to consider? 59; María Fernanda Guerra, Javier Ampuero, and Manuel Romero‐Gómez 11 Generic direct‐acting antiviral agents: do they work well? 66; Omar Salim Al Siyabi and Seng‐Gee Lim 12 Impact and management of patients with multiple hepatitis C virus genotypes 74; Peter Ferenci 13 Hepatitis C virus and injecting drug use: what are the challenges? 78; Olav Dalgard 14 Hepatitis B virus reactivation while on hepatitis C virus direct‐acting antiviral therapy: is that a real concern and when is it a concern? 82; Marina Serper 15 Drug–drug interactions with direct‐acting antivirals: when do we need to care? 86; Fiona Marra and David Back 16 Treatment of hepatitis C in children 94; Maureen M. Jonas 17 While direct‐acting antivirals are effective, are there any unique safety considerations? 97; Olivia Pietri, Félix Trottier‐Tellier, and Marc Bourlière 18 Harm reduction strategies to prevent new infections and reinfections among people who inject drugs: how effective are they? 106; Jason Grebely and Marianne Martinello 19 Hepatitis C virus therapy in advanced liver disease: treat or transplant and treat? 112; Chalermrat Bunchorntavakul and K. Rajender Reddy 20 Hepatocellular carcinoma and hepatitis C virus: which should be treated first? 117; Mario U. Mondelli, Andrea Lombardi, and Massimo Colombo 21 Should we incentivize patients to take hepatitis C virus therapy? 122; Ed Gane 22 Treating prisoners with hepatitis C: should we do it and how? 125; Seth Francis‐Graham and William Rosenberg 23 Use of hepatitis C virus‐positive organs for uninfected recipients in the era of effective and safe direct‐acting antivirals: pros and cons 132; Sirina Ekpanyapong and K. Rajender Reddy 24 Is real‐life hepatitis C virus therapy as effective as in clinical trials? 138; Jessica Su and Joseph K. Lim Section 2: HBV, HDV, and HEV 25 Management of acute hepatitis B infection: when should we offer antiviral therapy? 145; Emma Hathorn and David J. Mutimer 26 Rethinking the inactive carrier state: management of patients with low‐replicative HBeAg‐negative chronic hepatitis B and normal liver enzymes 150; María Buti, Mar Riveiro‐Barciela, and Rafael Esteban 27 Hepatitis B e antigen‐positive chronic hepatitis B infection with minimal changes on liver biopsy: what to do next 156; Apostolos Koffas and Patrick T. Kennedy 28 The management of hepatitis B virus in pregnancy 160; Henry L.Y. Chan 29 Treatment of hepatitis B in children 164; Maureen M. Jonas 30 Hepatitis B vaccine failures: how do we handle them? 169; Daniel Shouval 31 The stopping rules in hepatitis B virus therapy: can we provide any guidance? 175; Florian van Bömmel and Thomas Berg 32 Hepatitis C and hepatitis B coinfection 182; Chun‐Jen Liu and Jia‐Horng Kao 33 Chronic hepatitis E virus infection: is it reality or hype and where does it matter? 189; Nassim Kamar and Jacques Izopet 34 Hepatitis E virus vaccines: have they arrived – when, where and for whom? 193; Amit Goel and Rakesh Aggarwal Part III: Clinical Set‐up and the Future 35 Do we need expert hepatitis C virus treaters or are amateur treaters good enough? 203; Shyamasundaran Kottilil and Poonam Mathur 36 Hepatitis C vaccines: how close are we to the promised land? 208; Timothy Donnison, Senthil Chinnakannan, Paola Cicconi, and Eleanor Barnes 37 Elimination of hepatitis C virus in high‐prevalence, low‐income countries: is it feasible? 216; Mahmoud Abdo and Hadeel Gamal Eldeen 38 Hepatitis B virus diagnostics: anything new? 220; Dina Ginzberg, Robert J. Wong, and Robert G. Gish Part IV: Ongoing Controversies 39 Is hepatocellular carcinoma risk impacted favorably or unfavorably by hepatitis C virus therapy with direct‐acting antivirals? 233; Giuseppe Cabibbo, Calogero Cammà, and Antonio Craxì 40 Global elimination of hepatitis C virus by 2030: the optimistic view 238; Gregory J. Dore and Marianne Martinello 41 Global elimination of hepatitis C virus by 2030: the pessimistic view 244; Thomas G. Cotter and Michael Charlton Index 250
• Edition: Second edition
• Publisher Details: Chichester : Wiley Blackwell
• Publication Date: 2020
• Extent: 1 online resource
• Subjects: 616.3623; Hepatitis, Viral; Hepatitis, Viral -- Diagnosis; Hepatitis, Viral -- Treatment; Liver -- Diseases -- Diagnosis; Liver -- Diseases -- Treatment
• Languages: English
• ISBNs: 9781119533443; 9781119533436
• Related ISBNs: 9781119533399
• Notes: Note: Includes bibliographical references and index.; Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.